| Model Number |
310C25 |
| Medical Device Problem Codes |
Insufficient Device Problem Information (3190); Thickening of Material (4056); Device Stenosis (4066); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Foreign Body Reaction (1868); Mitral Valve Stenosis (1965); Mitral Valve Insufficiency/ Regurgitation (4451); Insufficient Information (4580)
|
| Date of Event |
01/17/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported the patient is being evaluated for a possible transcatheter valve-in-valve replacement.The reason for evaluation was reported as severe aortic regurgitation (ar).It was mentioned that possible pannus/thrombus was observed on the aortic valve.Additional information was received which stated that 6 weeks later, the 19mm aortic bioprosthetic valve was explanted and replaced with a 23mm valve of the same model.It was further reported that 4 years and 5 months post implant of the patients 25mm mitral bioprosthetic valve, it was also explanted and replaced with a 29mm valve of the same model.The reason for the replacement of the mitral valve was not reported.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b.1: adv evnt/prod prob.B.5: event description.H.6: coding.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that reported the reason for replacement of the mitral valve was mitral stenosis and pannus, as well as moderate mitral regurgitation.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|